For researchers in Canada who want to review the current option available through Great Northern Peptides, see the retatrutide page here
My takeaway As GLP-1 therapies become foundational treatments for diabetes and obesity, pricing strategy is becoming as important as scientific innovation
Patient Eligibility and Clinical Considerations Primary care doctors typically assess GLP-1 candidacy using BMI, comorbidity status (diabetes, hypertension, cardiovascular disease), contraindications, and medication interactions
Some of these other things that later down the line you can finally use the medications
This makes them ideal for daily use in anti-aging routines with minimal risk of side effects
Dietary Choices: Consuming high-calorie or unhealthy foods can counteract the effects of semaglutide